Pegus Cheryl 4

What Happened Cheryl Pegus, a director of Boston Scientific Corporation (BSX), made an open-market purchase of 1,770 shares on 2026-05-20. The shares were acquired at a weighted average price of $56.49 per share for a total reported value of $99,987. This transaction is a straight purchase (code P), which many investors view as a more informative "buy" signal than routine sales.

Key Details

• Transaction date: 2026-05-20 (reported on Form 4 filed 2026-05-21) — filing appears timely (next-day).
• Transaction type: Open-market purchase (P).
• Shares acquired: 1,770 shares.
• Price: Weighted average $56.49 per share; total value $99,987.
• Footnote: Purchases occurred in multiple trades at prices ranging from $56.49 to $56.5009 (inclusive). The reporting person will provide a per-price breakdown upon SEC or issuer request (Footnote F1).
• Shares owned after transaction: Not specified in the provided filing.

Context

• This was a purchase of company stock (not an option exercise, award, or gift). No derivatives or tax-withholding items were reported.
• The purchase size (~$100k) is modest for a corporate director; purchases can be interpreted as a personal investment but do not by themselves indicate company performance or insider intent.